Products of fibrinolytic cleavage and their clinical significance
Astedt, B.; Nilsson, I.M.
Folia Haematologica 97(1): 84-94
1972
ISSN/ISBN: 0323-4347 PMID: 4114588 Document Number: 51006
Document emailed within 1 workday
Related Documents
Alija, A.J.; Bresgen, N.; Bojaxhi, E.; Vogl, C.; Siems, W.; Eckl, P.M. 2010: Cytotoxicity of β-carotene cleavage products and its prevention by antioxidants Acta Biochimica Polonica 57(2): 217-221Vlassara, H. 1994: Recent progress on the biologic and clinical significance of advanced glycosylation end products Journal of Laboratory and Clinical Medicine 124(1): 19-30
Melamed, J.; Medicus, R.G.; Arnaout, M.A.; Colten, H.R. 1983: Induction of granulocyte histaminase release by particle-bound complement C3 cleavage products (C3b, C3bi) and IgG Journal of Immunology 131(1): 439-444
Xue, Z.M. 1981: The relationship between the estimation of fibrin fibrinogen degradation products and euglobulinolytic test and its clinical significance Zhonghua Nei Ke Za Zhi 20(2): 92-94
Mizutani, T.; Yoshida, K.; Kawazoe, S. 1994: Formation of toxic metabolites from thiabendazole and other thiazoles in mice. Identification of thioamides as ring cleavage products Drug Metabolism and Disposition: the Biological Fate of Chemicals 22(5): 750-755
Frick, V.U. 1976: Determination and importance of fibrinolytic degradation products in surgical operations Zentralblatt für Chirurgie 101(5): 294-297
Frick, G.; Göretzlehner, G.; Frick, U. 1976: Action of prostaglandin F2 alpha on heparinocytes and fibrinolytic split products Acta Biologica et Medica Germanica 35(8-9): 1255-1256
Frick, U.; Friemel, H. 1974: Quantitative determination of fibrinolytic degradation products by means of electroimmunodiffusion Folia Haematologica 101(5): 826-832
Frick, G.; Göretzlehner, G.; Frick, U. 1975: Demonstration of fibrinolytic split products during administration of hormonal contraceptives Zentralblatt für Gynakologie 97(16): 1001-1007
Nomura, E.; Kohriyama, T.; Yamaguchi, S.; Kajikawa, H.; Nakamura, S. 1996: Significance of the coagulation and fibrinolytic parameters as predictors for carotid atherosclerosis Rinsho Shinkeigaku 36(6): 741-745
Bube, F.W.; Egenolf, F. 1981: Detection of fibrinolytic split products in patient collections with disordered hemostasis. I. in pathologically verified lung cancer. II. in thrombotic/embolic occurrences Folia Haematologica 108(3): 447-454
Popov, A.I. 1987: Diagnostic significance of determining the fibrinolytic properties of urine in patients with bladder neoplasms Laboratornoe Delo 1: 32-33
Dube, R.K.; Sahaa, P.K.; Dube, B.; Katiyar, B.C.; Rao, P.V. 1980: Fibrinogen, fibrinogen degradation products and fibrinolytic activity in cerebrospinal fluid in stroke Indian Journal of Medical Research 72: 454-457
Frick, G.; Frick, U.; Brügmann, E. 1976: Behavior of heparinocytes and fibrinolytic degradation products under sulfobromophthalein or indocyanine green in patients with liver diseases or persons with healthy liver Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 31(15): 579-583
Sovová, V.; Trávnícek, M.; Hlozánek, I.; Cerná, H.; Sulová, A. 1984: Analysis of gag-myc proteins of partially transformation-defective mutants of avian myelocytomatosis virus strain MC29 by in vitro cleavage with protease p15: indication for the presence of specific cleavage site p15 in the myc domain of fusion protein Folia Biologica 30(3): 145-151
Earnshaw, J.J.; Westby, J.C.; Hopkinson, B.R.; Makin, G.S. 1988: Resting plasma fibrinolytic activity and fibrinolytic potential in peripheral vascular disease Journal of Cardiovascular Surgery 29(3): 300-305
Vinazzer, H. 1986: Clinical studies on the fibrinolytic action of pentosan polysulfate Folia Haematologica 113(1-2): 272-277
Vairel, E.G.; Choay, J.; Toulemonde, F. 1983: Current data on fibrinolytic agents used in clinical medicine Agressologie: Revue Internationale de Physio-Biologie et de Pharmacologie Appliquees Aux Effets de l'Agression 24(11): 555-558
Tadokoro, H. 1977: Experimental study on fibrinolytic phenomena of injured cerebral tissues. With special reference to the changes in fibrinolytic substances in glia tissues Nihon Geka Hokan. Archiv für Japanische Chirurgie 46(3): 258-277
Franzosi, M.G. 2001: Reperfusion after acute myocardial infarct with fibrinolytic therapy o combination reduced fibrinolytic therapy and a glycoprotein IIb/IIIa inhibitor: the GUSTO V study Italian Heart Journal. Suppl: Official Journal of the Italian Federation of Cardiology 2(9): 1034-1036